PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in Clinical Practice: An Expert Discussion with Prof Nicolas van Mieghem

Published: 25 October 2021

Views:
8172
Likes:
7

Views:
8172
Likes:
7
Share:

Now Playing
Part 4 | Session 4 of 4
Large bore access - basic concepts
Joost Daemen

Up Next

13m 46s

Part 5 iVAC 2L experience from CINRE hospital – Bratislava - Slovakia

3m 28s

Part 6 | Session 1 iVAC 2L experience from University Hospital Centre Zagreb: A Short Interview with Prof Joško Bulum
19m 12s

Part 6 | Session 2 Prof Joško Bulum presents his experience with the iVAC 2L

10m 30s

Part 7 iVAC 2L in High-Risk PCI Practical Issues
Joan Antoni Gómez-Hospital

17m 53s

Part 8 Dr Joan Antoni Gomez Hospital shares his experience on the iVAC 2L
Joan Antoni Gómez-Hospital

34m 9s

Part 1 PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in clinical practice Nicolas M Van Mieghem

26s

Part 2 | Session 1 Introduction Nicolas M Van Mieghem

4m 29s

Part 2 | Session 2 MCS indications and patient selection Nicolas M Van Mieghem

4m 10s

Part 2 | Session 3 Overview: Percutaneous MCS Systems Nicolas M Van Mieghem

3m 44s

Part 2 | Session 4 Key Findings: Clinical Experience high-risk PCI next generation MCS protected in Erasmus MC Nicolas M Van Mieghem

2m 50s

Part 2 | Session 5 Patient screening and access site management Nicolas M Van Mieghem

4m 9s

Part 2 | Session 6 iVAC 2L ® technology overview, procedure, technique and performance Nicolas M Van Mieghem

3m 6s

Part 2 | Session 7 Summary: iVAC 2L ® and Mechanical Unloading Nicolas M Van Mieghem

5m 5s

Part 2 | Session 8 Study Design and Population Nicolas M Van Mieghem

3m 45s

Part 2 | Session 9 Key Findings Nicolas M Van Mieghem

1m 18s

Part 2 | Session 10 iVAC 2L ® effects on Cardiac Mechanics Nicolas M Van Mieghem

1m 10s

Part 2 | Session 11 Pulse Trial Conclusion Nicolas M Van Mieghem

4m 57s

Part 2 | Session 12 Frequently Asked Questions Nicolas M Van Mieghem

2m 18s

Part 3 iVAC 2L ® - pVAD

18m 41s

Part 4 | Session 1 Pulsatile LV support during high-risk PCI (the PulseCath iVAC 2L) Joost Daemen

10m 6s

Part 4 | Session 2 The concept of pulsatile LV support (the PulseCath iVAC 2L) Joost Daemen

9m 48s

Part 4 | Session 3 Pulsatile vs. Continuous percutaneous MCS Joost Daemen

Average (ratings)

No ratings

Your rating

Overview

In this video series, Professor Nicolas van Mieghem will discuss the benefits of iVAC 2L ® in clinical practice and will share the learnings and key outcomes from the Pulse Trial, and the effect of next generation pulsatile mechanical circulatory support (MCS).

This video is supported by PulseCath in collaboration with their co-sponsors: CardiRad, Sanomed, LeviBio, Thomy F.E., Sonimed and Dot Medical.

Click Here for Publication: Effect of next generation pulsatile mechanical circulatory support on cardiac mechanics - The PULSE trial

This video series is sponsored by:

Key Learning Objectives

Learn when to use the short term percutaneous ventricular assist device (pVAD), iVAC 2L ® in clinical practice
Understand the differences between pulsatile and continuous flow
Understand the technology behind the device
Gain a better understanding of how the iVAC 2L ® is more efficient
Learn how to identify the right patient (HR PCI)
Learn when to use iVAC 2L ® vs Impella
Further understanding of large bore access management

Target Audience

Interventional Cardiologists
Cardiac Surgeons
Cardiac Nurses
Cath Lab Nurses
ICU Doctors
Perfusionists
Cath Lab Technicians

More from this programme

Part 1

Full Programme - PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in Clinical Practice: An Expert Discussion with Prof Nicolas van Mieghem

Watch the entire webinar on the benefits of iVAC 2L ® in clinical practice brought to you by Prof Nicolas van Mieghem

1 session
PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in clinical practice	Watch now

Part 2

Chapters of Programme - PULSE-trial: Summarising the Clinical Outcomes and Benefits of iVAC 2L ® in Clinical Practice: An Expert Discussion with Prof Nicolas van Mieghem

Discover the benefits of iVAC 2L ® in clinical practice in shorter clips here

12 sessions
Introduction	Watch now
MCS indications and patient selection	Watch now
Overview: Percutaneous MCS Systems	Watch now
Key Findings: Clinical Experience high-risk PCI next generation MCS protected in Erasmus MC	Watch now
Patient screening and access site management	Watch now
iVAC 2L ® technology overview, procedure, technique and performance	Watch now
Summary: iVAC 2L ® and Mechanical Unloading	Watch now
Study Design and Population	Watch now
Key Findings	Watch now
iVAC 2L ® effects on Cardiac Mechanics	Watch now
Pulse Trial Conclusion	Watch now
Frequently Asked Questions	Watch now

Part 3

iVAC 2L ® - pVAD procedure

Watch the animation video of the iVAC 2L ® - pVAD procedure

1 session
iVAC 2L ® - pVAD	Watch now

Part 4

Pulsatile LV support during high-risk PCI

Dr Joost Daemen from Erasmus Medical Centre in the Netherlands talks through some of the basic concepts of pulsatile LV support during high-risk PCI

4 sessions
Pulsatile LV support during high-risk PCI (the PulseCath iVAC 2L)	Watch now
The concept of pulsatile LV support (the PulseCath iVAC 2L)	Watch now
Pulsatile vs. Continuous percutaneous MCS	Watch now
Large bore access - basic concepts	Watch now

Part 5

iVAC 2L experience from CINRE hospital – Bratislava - Slovakia

Dr Ota Hilnomaz reviews his experience of the iVAC 2L

1 session
iVAC 2L experience from CINRE hospital – Bratislava - Slovakia	Watch now

Part 6

iVAC 2L experience from University Hospital Centre Zagreb, Zagreb, HR

Prof Joško Bulum, University Hospital Centre Zagreb, Zagreb, HR shares his experience on the iVAC 2L and treating more complicated PCI patients.

2 sessions
iVAC 2L experience from University Hospital Centre Zagreb: A Short Interview with Prof Joško Bulum	Watch now
Prof Joško Bulum presents his experience with the iVAC 2L	Watch now

Part 7

Procedure IVAC 2L in high risk PCI University Hospital of Bellvitge, Barcelona, (Spanish)

Dr Joan Antoni Gomez-Hospital (University Hospital of Bellvitge, Barcelona, ES) shares his experience on the iVAC 2L and the practical issues.

1 session
iVAC 2L in High-Risk PCI Practical Issues	Watch now

Part 8

iVAC 2L experience from University Hospital of Bellvitge, Barcelona, ES

1 session
Dr Joan Antoni Gomez Hospital shares his experience on the iVAC 2L	Watch now

Faculty Biographies

Joost Daemen

Interventional Cardiologist

Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.

View full profile